Differential expression of host biomarkers in saliva and serum samples from individuals with suspected pulmonary tuberculosis

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Phalane, Khutso G ^a   Kriel, Magdalena ^a   Loxton, Andre G ^a   Menezes, Angela ^a   Stanley, Kim ^a   Van Der Spuy, Gian D ^a   Walzl, Gerhard ^a   Chegou, Novel N ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD40 LIGAND; EPIDERMAL GROWTH FACTOR; FRACTALKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE A; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LUNG TUBERCULOSIS; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SALIVA; SALIVA LEVEL; SERUM; BLOOD; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOASSAY; METABOLISM; MIDDLE AGED; PILOT STUDY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY;

ADULT; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SALIVA; TUBERCULOSIS, PULMONARY;

EID: 84890036132     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/981984     Document Type: Article

References (45)

1. World Health Organisation, Global tuberculosis report 2012. 2012
2. Murray C. J. L., DeJonghe E., Chum H. J., Nyangulu D. S., Salomao A., Styblo K., Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries. The Lancet 1991 338 8778 1305 1308 2-s2.0-0026046360 10.1016/0140-6736(91)92600-7
3. Apers L., Mutsvangwa J., Magwenzi J., Chigara N., Butterworth A., Mason P., Van der Stuyft P., A comparison of direct microscopy, the concentration method and the Mycobacteria Growth Indicator Tube for the examination of sputum for acid-fast bacilli. International Journal of Tuberculosis and Lung Disease 2003 7 4 376 381 2-s2.0-0037388936 (Pubitemid 36433132)
4. Chegou N. N., Hoek K. G., Kriel M., Warren R. M., Victor T. C., Walzl G., Tuberculosis assays: past, present and future. Expert Review of Anti-Infective Therapy 2011 9 4 457 469 2-s2.0-79955103540 10.1586/eri.11.23
5. Hanna B. A., Ebrahimzadeh A., Elliott L. B., Morgan M. A., Novak S. M., Rusch-Gerdes S., Acio M., Dunbar D. F., Holmes T. M., Rexer C. H., Savthyakumar C., Vannier A. M., Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. Journal of Clinical Microbiology 1999 37 3 748 752 2-s2.0-0033062549 (Pubitemid 29091296)
6. Boehme C. C., Nabeta P., Hillemann D., Nicol M. P., Shenai S., Krapp F., Allen J., Tahirli R., Blakemore R., Rustomjee R., Milovic A., Jones M., O'Brien S. M., Persing D. H., Ruesch-Gerdes S., Gotuzzo E., Rodrigues C., Alland D., Perkins M. D., Rapid molecular detection of tuberculosis and rifampin resistance. The New England Journal of Medicine 2010 363 11 1005 1015 2-s2.0-77956497725 10.1056/NEJMoa0907847
7. Steingart K. R., Sohn H., Schiller I., Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database of Systematic Reviews 2013 1 CD009593
8. Trébucq A., Enarson D. A., Chiang C. Y., Van Deun A., Harries A. D., Boillot F., Detjen A., Fujiwara P. I., Graham S. M., Monedero I., Rusen I. D., Rieder H. L., Xpert MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how? International Journal of Tuberculosis and Lung Disease 2011 15 12 1567 1572 2-s2.0-81455138225 10.5588/ijtld.11.0392
9. Marais B. J., Pai M., New approaches and emerging technologies in the diagnosis of childhood tuberculosis. Paediatric Respiratory Reviews 2007 8 2 124 133 2-s2.0-34250167238 10.1016/j.prrv.2007.04.002 (Pubitemid 46900102)
10. Chegou N. N., Walzl G., Bolliger C. T., Diacon A. H., van den Heuvel M. M., Evaluation of adapted whole-blood interferon- γ release assays for the diagnosis of pleural tuberculosis. Respiration 2008 76 2 131 138 2-s2.0-49949089417 10.1159/000128575
11. Munk M. E., Arend S. M., Brock I., Ottenhoff T. H. M., Andersen P., Use of ESAT-6 and CFP-10 antigens for diagnosis of extrapulmonary tuberculosis. Journal of Infectious Diseases 2001 183 1 175 176 2-s2.0-0035168872 10.1086/317663 (Pubitemid 32043061)
12. Schipper R. G., Silletti E., Vingerhoeds M. H., Saliva as research material: biochemical, physicochemical and practical aspects. Archives of Oral Biology 2007 52 12 1114 1135 2-s2.0-35548992313 10.1016/j.archoralbio.2007.06. 009 (Pubitemid 350018725)
13. Gustafsson A., Ajeti V., Ljunggren L., Detection of suPAR in the saliva of healthy young adults: comparison with plasma levels. Biomarker Insights 2011 6 119 125 2-s2.0-83455259390 10.4137/BMI.S8326
14. Pant Pai N., Joshi R., Dogra S., Taksande B., Kalantri S. P., Pai M., Narang P., Tulsky J. P., Reingold A. L., Evaluation of diagnostic accuracy, feasibility and client preference for rapid oral fluid-based diagnosis of HIV infection in rural India. PLoS ONE 2007 2 4, article e367 2-s2.0-34447547368 10.1371/journal.pone.0000367
15. Boehme C., Molokova E., Minja F., Geis S., Loscher T., Maboko L., Koulchin V., Hoelscher M., Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Transactions of the Royal Society of Tropical Medicine and Hygiene 2005 99 12 893 900 2-s2.0-27244439666 10.1016/j.trstmh.2005.04.014 (Pubitemid 41511449)
16. Kingsmore S. F., Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nature Reviews Drug Discovery 2006 5 4 310 320 2-s2.0-33645463194 10.1038/nrd2006
17. Luque-Garcia J. L., Neubert T. A., Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry. Journal of Chromatography A 2007 1153 1-2 259 276 2-s2.0-34248578524 10.1016/j.chroma.2006. 11.054 (Pubitemid 46755182)
18. Mutetwa R., Boehme C., Dimairo M., Bandason T., Munyati S. S., Mangwanya D., Mungofa S., Butterworth A. E., Mason P. R., Corbett E. L., Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients. International Journal of Tuberculosis and Lung Disease 2009 13 10 1253 1259 2-s2.0-70350102835
19. Thakur A., Pedersen L. E., Jungersen G., Immune markers and correlates of protection for vaccine induced immune responses. Vaccine 2012 30 4907 4920
20. Wallis R. S., Kim P., Cole S., Tuberculosis biomarkers discovery: developments, needs, and challenges. The Lancet Infectious Diseases 2013 13 362 372
21. Walzl G., Ronacher K., Hanekom W., Scriba T. J., Zumla A., Immunological biomarkers of tuberculosis. Nature Reviews Immunology 2011 11 5 343 354 2-s2.0-79955480087 10.1038/nri2960
22. Malek T. R., The biology of interleukin-2. Annual Review of Immunology 2008 26 453 479 2-s2.0-41949097030 10.1146/annurev.immunol.26.021607.090357 (Pubitemid 351600382)
23. Biselli R., Mariotti S., Sargentini V., Sauzullo I., Lastilla M., Mengoni F., Vanini V., Girardi E., Goletti D., D'Amelio R., Nisini R., Detection of interleukin-2 in addition to interferon- γ discriminates active tuberculosis patients, latently infected individuals, and controls. Clinical Microbiology and Infection 2010 16 8 1282 1284 2-s2.0-77955153216 10.1111/j.1469-0691.2009.03104.x
24. Wang S., Diao N., Lu C., Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population. PLoS ONE 2012 7 e51338
25. Kishimoto T., IL-6: from its discovery to clinical applications. International Immunology 2010 22 5 347 352 2-s2.0-77953980528 10.1093/intimm/dxq030
26. Djoba Siawaya J. F., Beyers N., van Helden P., Walzl G., Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis. Clinical and Experimental Immunology 2009 156 1 69 77 2-s2.0-61849099439 10.1111/j.1365-2249.2009.03875.x
27. Hussain R., Kaleem A., Shahid F., Dojki M., Jamil B., Mehmood H., Dawood G., Dockrell H. M., Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. Journal of Immunological Methods 2002 264 1-2 95 108 2-s2.0-0036606365 10.1016/S0022-1759(02)00092-3 (Pubitemid 34615896)
28. Fraticelli P., Sironi M., Bianchi G., D'Ambrosio D., Albanesi C., Stoppacciaro A., Chieppa M., Allavena P., Ruco L., Girolomoni G., Sinigaglia F., Vecchi A., Mantovani A., Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. The Journal of Clinical Investigation 2001 107 9 1173 1181 2-s2.0-0035012168 (Pubitemid 32422914)
29. Lehner T., Wang Y., Whittall T., Seidl T., Innate immunity and HIV-1 infection. Advances in Dental Research 2011 23 1 19 22 2-s2.0-79954615347 10.1177/0022034511399081
30. Maurer M., von Stebut E., Macrophage inflammatory protein-1. International Journal of Biochemistry and Cell Biology 2004 36 10 1882 1886 2-s2.0-2942559019 10.1016/j.biocel.2003.10.019 (Pubitemid 38760018)
31. Chegou N. N., Black G. F., Kidd M., van Helden P. D., Walzl G., Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulmonary Medicine 2009 9, article 21 2-s2.0-67649280552 10.1186/1471-2466-9-21
32. Kellar K. L., Gehrke J., Weis S. E., Mahmutovic-Mayhew A., Davila B., Zajdowicz M. J., Scarborough R., LoBue P. A., Lardizabal A. A., Daley C. L., Reves R. R., Bernardo J., Campbell B. H., Whitworth W. C., Mazurek G. H., Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens. PLoS ONE 2011 6 11 2-s2.0-81455144571 10.1371/journal.pone.0026545 e26545
33. Chegou N. N., Detjen A. K., Thiart L., Utility of host markers detected in quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting. PLoS ONE 2013 8 e64226
34. Gruys E., Toussaint M. J. M., Niewold T. A., Koopmans S. J., Acute phase reaction and acute phase proteins. Journal of Zhejiang University 2005 6 11 1045 1056 2-s2.0-27944460308 10.1631/jzus.2005.B1045 (Pubitemid 43083934)
35. Shaikh M. K., Samo J. A., Devrajani B. R., Shah S. Z. A., Shaikh S., Shaikh I., C-reactive protein in patients with pulmonary tuberculosis. World Applied Sciences Journal 2012 17 2 140 144 2-s2.0-84859533399
36. Wilson D., Badri M., Maartens G., Performance of serum c-reactive protein as a screening test for smear-negative tuberculosis in an ambulatory high HIV prevalence population. PLoS ONE 2011 6 1 2-s2.0-79251585957 10.1371/journal. pone.0015248 e15248
37. Haghighi L., Doust J. Y., C-reactive protein in pulmonary tuberculosis. Diseases of the Chest 1966 50 6 624 626 2-s2.0-0013979807
38. Rao S., Bernhardt V., Serum C-reactive protein in pulmonary tuberculosis: correlation with bacteriological load and extent of disease. Infectious Diseases in Clinical Practice 2009 17 5 314 316 2-s2.0-70349728875 10.1097/IPC.0b013e3181a4c73d
39. Raynes J. G., Cooper E. H., Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease. Journal of Clinical Pathology 1983 36 7 798 803 2-s2.0-0020636591 (Pubitemid 13069314)
40. Eriksen N., Mackewicz A., Kushner I., Boumann H., The serum amyloid protein A lipoprotein family. Acute Phase Proteins: Molecular Biology Biochemistry and Clinical Applications 1993 Boca Raton, Fla, USA CRC Press 93 106
41. Singh P. P., Kaur S., Serum amyloid P-component in murine tuberculosis: induction kinetics and intramacrophage Mycobacterium tuberculosis growth inhibition in vitro. Microbes and Infection 2006 8 2 541 551 2-s2.0-32244434553 10.1016/j.micinf.2005.08.007 (Pubitemid 43214618)
42. Kagami H., Hiramatsu Y., Hishida S., Okazaki Y., Horie K., Oda Y., Ueda M., Salivary growth factors in health and disease. Advances in Dental Research 2000 14 99 102 2-s2.0-0034584243
43. Ergun S., Troşala Ş. C., Warnakulasuriya S., Özel S., Önal A. E., Ofluolu D., Güven Y., Tanyeri H., Evaluation of oxidative stress and antioxidant profile in patients with oral lichen planus. Journal of Oral Pathology and Medicine 2011 40 4 286 293 2-s2.0-79952828775 10.1111/j.1600-0714.2010.00955.x
44. Kaufman E., Lamster I. B., The diagnostic applications of saliva-a review. Critical Reviews in Oral Biology and Medicine 2002 13 2 197 212 2-s2.0-0036071261 (Pubitemid 34791218)
45. Branson B. M., FDA approves OraQuick for use in saliva. On March 25, the FDA approved the first rapid test for HIV in oral fluids. AIDS Clinical Care 2004 16 5 39 2-s2.0-2942737339